A Case of Tjalma Syndrome Coincidentally Accompanied by an Ovarian Teratoma Successfully Treated with Intravenous Immunoglobulin-G Adjunctive Therapy.
- Author:
Eun Kyoung PARK
1
;
Seung Geun LEE
;
Ik Soo BYON
;
Sun Hee LEE
;
Seong Jun LEE
;
Yoon Jeong NAM
;
Ji Hye PARK
;
Geun Tae KIM
;
Young Eun PARK
;
Seong Hu PARK
;
Joung Wook LEE
;
Jun Hee LEE
;
Seung Hoon BAEK
Author Information
- Publication Type:Case Report
- Keywords: Systemic lupus erythematosus; Intravenous immunoglobulin; Ascites; Pleural effusion
- MeSH: Adult; Ascites; Cyclophosphamide; Female; Hand; Humans; Lupus Erythematosus, Systemic; Meigs Syndrome; Pleural Effusion; Teratoma*
- From:Journal of Rheumatic Diseases 2014;21(2):77-81
- CountryRepublic of Korea
- Language:English
- Abstract: Tjalma or pseudo-pseudo Meigs' syndrome is a clinical condition that is characterized with ascites, pleural effusion, and increased serum CA-125 levels in patients with systemic lupus erythematosus (SLE) without the presence of ovarian tumor. On the other hand, Meigs' and pseudo-Meigs' syndromes represent the same manifestations with ovarian tumor. In this case report, we present a 43-year-old SLE patient suffering from Tjalma syndrome with the coexistence of incidental ovarian teratoma, who was successfully treated with intravenous immunoglobulin-G adjunctive therapy after inadequate response to surgical excision of the ovarian tumor, steroid, and cyclophosphamide pulse therapy.
